Interesting, serum molar ratio of total IGF-1/IGFBP-1 was significantly higher in SSc-ILD compared to SSc-no ILD patients (p < 0.01), suggesting an elevated level of free IGF-1 in patients with SSc-ILD. This evidence concerns the gene IGFBP1 and systemic sclerosis.